NCT05940857 US National OCS Liver Perfusion (OLP) Registry
| NCT ID | NCT05940857 |
| Status | Recruiting |
| Phase | — |
| Sponsor | TransMedics |
| Condition | Liver Transplant |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2021-10-14 |
| Primary Completion | 2031-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2021-10-14 with a primary completion date of 2031-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight. TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.
Eligibility Criteria
All liver transplant recipients.
Contact & Investigator
Ahmed Elbetanony, MD
STUDY DIRECTOR
TransMedics
Frequently Asked Questions
Who can join the NCT05940857 clinical trial?
This trial is open to participants of all sexes, studying Liver Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05940857 currently recruiting?
Yes, NCT05940857 is actively recruiting participants. Contact the research team at kjork@transmedics.com for enrollment information.
Where is the NCT05940857 trial being conducted?
This trial is being conducted at Birmingham, United States, Phoenix, United States, La Jolla, United States, San Francisco, United States and 11 additional locations.
Who is sponsoring the NCT05940857 clinical trial?
NCT05940857 is sponsored by TransMedics. The principal investigator is Ahmed Elbetanony, MD at TransMedics. The trial plans to enroll 100,000 participants.